|
U0126-EtOH
|
2,3-雙[氨基[(2-氨基苯基)硫]亞甲基]丁二腈乙醇鹽
|
1173097-76-1
|
|
Dabrafenib
|
達(dá)帕菲尼
|
1195765-45-7
|
|
VE-821
|
3-氨基-6-[4-(甲基磺?；?苯基]-N-苯基-2-吡嗪甲酰胺
|
1232410-49-9
|
|
Venetoclax (ABT-199)
|
維納妥拉(ABT-199)
|
1257044-40-8
|
|
(+)-JQ1
|
(S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-基)乙酸叔丁酯
|
1268524-70-4
|
|
Capivasertib (AZD5363)
|
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羥基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺
|
1143532-39-1
|
|
A66
|
A66
|
1166227-08-2
|
|
Ribociclib (LEE011)
|
瑞博西尼
|
1211441-98-3
|
|
WZ4002
|
WZ4002
|
1213269-23-8
|
|
IWR-1-endo
|
IWR-1
|
1127442-82-3
|
|
CX-5461
|
CX-5461
|
1138549-36-6
|
|
Cabozantinib malate (XL184)
|
卡博替尼蘋果酸鹽
|
1140909-48-3
|
|
Pyrazolanthrone (SP600125)
|
吡唑蒽酮(SP600125)
|
129-56-6
|
|
Lappaol B
|
牛蒡酚B
|
62359-60-8
|
|
Y-27632 2HCl
|
Y27632 (HYDROCHLORIDE)
|
129830-38-2
|
|
Vorinostat(SAHA)
|
伏立諾他
|
149647-78-9
|
|
SB203580
|
4-(4-氟苯基)-2-(4-甲基亞磺?；交?-5-(4-吡啶基)-1H-咪唑
|
152121-47-6
|
|
Imatinib (STI571)
|
伊馬替尼
|
152459-95-5
|
|
Tyrphostin B42 (AG-490)
|
酪氨酸磷酸化抑制劑AG 490
|
133550-30-8
|
|
GSK2606414
|
GSK2606414
|
1337531-36-8
|
|
Irinotecan HCI Trihydrate
|
鹽酸伊立替康三水合物
|
136572-09-3
|
|
RGFP966
|
(2E)-N-(2-氨基-4-氟苯基)-3-[1-(3-苯基-2-丙烯-1-基)-1H-吡唑-4-基]-2-丙烯酰胺
|
1396841-57-8
|
|
Tazemetostat (EPZ-6438)
|
EPZ-6438
|
1403254-99-8
|
|
JNK-IN-8
|
JNK-IN-8
|
1410880-22-6
|
|
Osimertinib (AZD9291)
|
奧斯替尼
|
1421373-65-0
|
|
Perifosine (KRX-0401)
|
哌立福辛
|
157716-52-4
|
|
Everolimus (RAD001)
|
依維莫司
|
159351-69-6
|
|
PD98059
|
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮
|
167869-21-8
|
|
Bortezomib (PS-341)
|
硼替佐米
|
179324-69-7
|
|
Z-VAD-FMK
|
氟甲基酮
|
187389-52-2
|
|
BAY 11-7082
|
(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE
|
19542-67-7
|
|
SH-4-54
|
SH-4-54
|
1456632-40-8
|
|
Go 6983
|
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮
|
133053-19-7
|
|
Alpelisib (BYL719)
|
阿培利司
|
1217486-61-7
|
|
Dorsomorphin dihydrochloride
|
BML-275
|
1219168-18-9
|
|
Gemcitabine HCl
|
鹽酸吉西他濱
|
122111-03-9
|
|
Torin 1
|
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮
|
1222998-36-8
|
|
Sapanisertib (MLN0128)
|
沙帕色替
|
1224844-38-5
|
|
Thiazovivin
|
THIAZOVIVIN
|
1226056-71-8
|
|
Berzosertib (VE-822)
|
VE-822
|
1232416-25-9
|
|
Wnt-C59
|
PORCN酶活性和WNT抑制劑(WNT-C59)
|
1243243-89-1
|
|
LGK-974 (WNT974)
|
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-聯(lián)吡啶]-5-乙酰胺
|
1243244-14-5
|
|
Tubastatin A
|
TUBASTATIN A
|
1252003-15-8
|
|
Alectinib (CH5424802)
|
艾樂替尼
|
1256580-46-7
|
|
BAPTA-AM
|
BAPTA-AM
|
126150-97-8
|
|
Fulvestrant
|
氟維司瓊
|
129453-61-8
|
|
Verteporfin
|
維替泊芬
|
129497-78-5
|
|
H 89 2HCl
|
H-89二鹽酸鹽
|
130964-39-5
|
|
Ricolinostat (ACY-1215)
|
ACY1215
|
1316214-52-4
|
|
Bisindolylmaleimide I (GF109203X)
|
GF109203X
|
133052-90-1
|
|
Adavosertib (MK-1775)
|
MK-1775
|
955365-80-7
|
|
Daclatasvir (BMS-790052)
|
達(dá)卡他韋
|
1009119-64-5
|
|
Vistusertib (AZD2014)
|
3-[2,4-雙((3S)-3-甲基嗎啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺
|
1009298-59-2
|
|
Silmitasertib (CX-4945)
|
CX-4945
|
1009820-21-6
|
|
PF-04691502
|
2-氨基-8-[反式-4-(2-羥基乙氧基)環(huán)己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮
|
1013101-36-4
|
|
Ceritinib (LDK378)
|
色瑞替尼
|
1032900-25-6
|
|
AZD4547
|
AZD-4547
|
1035270-39-3
|
|
Bemcentinib (R428)
|
R428
|
1037624-75-1
|
|
Fasudil Hydrochloride
|
鹽酸法舒地爾
|
105628-07-7
|
|
LDN193189
|
LDN-193189
|
1062368-24-4
|
|
LDN-193189 HCl
|
LDN-193189 HCl
|
1062368-62-0
|
|
Ixazomib (MLN2238)
|
艾沙佐米
|
1072833-77-2
|
|
LDC000067
|
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺
|
1073485-20-7
|
|
Afatinib (BIBW2992)
|
阿法替尼
|
439081-18-2
|
|
Selisistat (EX 527)
|
EX-527
|
49843-98-3
|
|
Chloroquine diphosphate
|
磷酸氯喹
|
50-63-5
|
|
3-Methyladenine
|
6-氨基-3-甲基嘌呤
|
5142-23-4
|
|
Tofacitinib citrate
|
枸櫞酸托法替尼
|
540737-29-9
|
|
KU55933 (ATM Kinase Inhibitor)
|
2-嗎啉-4-基-6-噻蒽-1-基吡喃-4-酮
|
587871-26-9
|
|
Selumetinib (AZD6244)
|
司美替尼
|
606143-52-6
|
|
Regorafenib (BAY 73-4506)
|
瑞格非尼
|
755037-03-7
|
|
BI 2536
|
BI 2536
|
755038-02-9
|
|
Olaparib (AZD2281)
|
奧拉帕尼
|
763113-22-0
|
|
Palbociclib hydrochloride
|
鹽酸帕博西尼
|
827022-32-2
|
|
Palbociclib Isethionate
|
帕博西尼羥乙基磺酸鹽
|
827022-33-3
|
|
Idelalisib (CAL-101)
|
艾代拉里斯
|
870281-82-6
|
|
Trametinib (GSK1120212)
|
曲美替尼
|
871700-17-3
|
|
Infigratinib (BGJ398)
|
FGFR抑制劑(NVP-BGJ398)
|
872511-34-7
|
|
Ivacaftor (VX-770)
|
依伐卡托
|
873054-44-5
|
|
Crizotinib (PF-02341066)
|
克唑替尼
|
877399-52-5
|
|
Veliparib (ABT-888)
|
維利帕尼
|
912444-00-9
|
|
Dactolisib (BEZ235)
|
NVP-BEZ235
|
915019-65-7
|
|
Enzalutamide (MDV3100)
|
恩雜魯胺
|
915087-33-1
|
|
Vemurafenib (PLX4032)
|
維羅非尼
|
918504-65-1
|
|
PLX-4720
|
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺
|
918505-84-7
|
|
Ibrutinib (PCI-32765)
|
依魯替尼
|
936563-96-1
|
|
Lumacaftor (VX-809)
|
魯瑪卡托
|
936727-05-8
|
|
Ruxolitinib (INCB018424)
|
魯索利替尼
|
941678-49-5
|
|
SCH772984
|
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)對二氮己環(huán)-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺
|
942183-80-4
|
|
Torkinib (PP242)
|
PP242
|
1092351-67-1
|
|
BIX02189
|
3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亞甲基]-2,3-二氫-N,N-二甲基-2-氧代-1H-吲哚-6-甲酰胺
|
1094614-85-3
|
|
Plerixafor (AMD3100)
|
普樂沙福
|
110078-46-1
|
|
Dacomitinib (PF-00299804)
|
達(dá)克替尼
|
1110813-31-4
|
|
DAPT (GSI-IX)
|
DAPT
|
208255-80-5
|
|
Entinostat (MS-275)
|
恩替諾特
|
209783-80-2
|
|
CHIR-99021 (CT99021)
|
CHIR-99021
|
252917-06-9
|
|
XAV-939
|
3,5,7,8-四氫-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮
|
284028-89-3
|
|
SB431542
|
SB-431542
|
301836-41-9
|
|
Dasatinib (BMS-354825)
|
達(dá)沙替尼
|
302962-49-8
|
|
Panobinostat (LBH589)
|
帕比司他
|
404950-80-7
|